Onset of Efficacy Following Oral Treatment With Lasmiditan for the Acute Treatment of Migraine: Integrated Results From 2 Randomized Double‐Blind Placebo‐Controlled Phase 3 Clinical Studies

OBJECTIVE: To expand on available information on the efficacy of oral lasmiditan for the acute treatment of migraine with particular focus on the timing of the effect and on its impact on migraine‐associated symptoms. BACKGROUND: Lasmiditan is a novel selective 5‐hydroxytryptamine 1F receptor agonis...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Headache
Main Authors: Ashina, Messoud, Vasudeva, Raghavendra, Jin, Leah, Lombard, Louise, Gray, Elizabeth, Doty, Erin G., Yunes‐Medina, Laura, Kinchen, Kraig S., Tassorelli, Cristina
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2019
Assuntos:
Research Submissions
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6899640/
https://ncbi.nlm.nih.gov/pubmed/31529622
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/head.13636
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados